Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:38 pm Sale | 13G | UROGEN PHARMA LTD URGN | Consonance Capital Management LP | 0 0% | -1,515,422 (Position Closed) | View |
| 2020-02-14 4:01 pm Sale | 13G | CORCEPT THERAPEUTICS INCORPORA CORT | Consonance Capital Management LP | 0 0% | -6,211,964 (Position Closed) | View |
| 2020-02-14 4:01 pm Sale | 13G | SESEN BIO INC SESN | Consonance Capital Management LP | 0 0% | -7,523,296 (Position Closed) | View |
| 2020-02-14 4:01 pm Sale | 13G | SAVARA INC SVRA | Consonance Capital Management LP | 0 0% | -3,093,690 (Position Closed) | View |
| 2020-02-14 4:01 pm Sale | 13G | VANDA PHARMACEUTICALS INC VNDA | Consonance Capital Management LP | 0 0% | -4,658,759 (Position Closed) | View |
| 2020-02-14 3:49 pm Sale | 13G | RETROPHIN, INC. RTRX | Consonance Capital Management LP | 2,314,421 5.39% | -1,717,702 (-42.60%) | View |
| 2020-02-14 3:40 pm Sale | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Consonance Capital Management LP | 2,363,724 8.94% | -216,060 (-8.38%) | View |
| 2020-02-14 2:16 pm Sale | 13G | VERICEL CORPORATION VCEL | Consonance Capital Management LP | 1,556,137 3.48% | -2,661,955 (-63.11%) | View |
| 2020-02-14 2:15 pm Sale | 13G | UNIQURE N V QURE | Consonance Capital Management LP | 929,036 2.13% | -967,190 (-51.01%) | View |
| 2020-02-14 2:10 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | Consonance Capital Management LP | 2,888,888 6.04% | 2,888,888 (New Position) | View |
| 2020-02-14 2:09 pm Purchase | 13G | OMEROS CORPORATION OMER | Consonance Capital Management LP | 3,195,796 6.42% | 3,195,796 (New Position) | View |
| 2020-02-14 1:35 pm Purchase | 13G | LIMINAL BIOSCIENCES INC LMNL | Consonance Capital Management LP | 3,287,311 14.1% | 3,287,311 (New Position) | View |
| 2020-02-14 1:34 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Consonance Capital Management LP | 6,127,434 9.76% | 1,317,356 (+27.39%) | View |
| 2020-02-14 1:32 pm Purchase | 13G | KADMON HLDGS LLC COM KDMN | Consonance Capital Management LP | 15,642,064 9.8% | 15,642,064 (New Position) | View |
| 2020-02-14 1:30 pm Purchase | 13G | IVERIC BIO INC ISEE | Consonance Capital Management LP | 3,426,365 8.24% | 3,426,365 (New Position) | View |
| 2020-02-14 1:20 pm Purchase | 13G | CAREDX INC CDNA | Consonance Capital Management LP | 2,121,976 5% | 2,121,976 (New Position) | View |
| 2020-02-14 1:18 pm Purchase | 13G | AURINIA PHARMACEUTICALS INC AUPH | Consonance Capital Management LP | 6,625,671 3.48% | 6,625,671 (New Position) | View |
| 2020-02-14 12:37 pm Purchase | 13G | ASSEMBLY BIOSCIENCES INC ASMB | Consonance Capital Management LP | 1,878,395 7.21% | 1,878,395 (New Position) | View |
| 2020-02-14 12:34 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Consonance Capital Management LP | 4,772,190 6.27% | 4,772,190 (New Position) | View |
| 2020-02-14 12:23 pm Purchase | 13G | AXOGEN, INC. AXGN | Consonance Capital Management LP | 2,986,386 7.57% | 2,986,386 (New Position) | View |